Page 18 - GTM-4-3

Global Translational Medicine Inflammation in CVD: Mechanisms and markers

Acknowledgments doi: 10.1161/CIR.0000000000001209

None. 3. Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s
essential 8: Updating and enhancing the American
Funding heart association’s construct of cardiovascular health:
A presidential advisory from the American heart association.
None. Circulation. 2022;146(5):e18-e43.
Conflict of interest doi: 10.1161/CIR.0000000000001078

Krishnaswami Vijayraghavan is the Guest Editor for this 4. Sun J, Li Y, Zhao M, et al. Association of the American
heart association’s new “life’s essential 8” with all-cause
special issue but was not in any way involved in the editorial and cardiovascular disease-specific mortality: Prospective
and peer-review process conducted for this paper, directly cohort study. BMC Med. 2023;21(1):116.
or indirectly. While, Corina Grancorvitz is an employee
of Kiniksa Pharmaceuticals but declared no known doi: 10.1186/s12916-023-02824-8
competing financial interests or personal relationships 5. Alfaddagh A, Martin SS, Leucker TM, et al. Inflammation
that could have influenced the work reported in this and cardiovascular disease: From mechanisms to
paper. Other authors declared that they have no known therapeutics. Am J Prev Cardiol. 2020;4:100130.
competing financial interests or personal relationships that doi: 10.1016/j.ajpc.2020.100130
could have influenced the work reported in this paper.
6. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque
Author contributions formation and rupture. Circ Res. 2014;114(12):1852-1866.
Conceptualization: Tushar Menon, Krishnaswami doi: 10.1161/CIRCRESAHA.114.302721
Vijayraghavan 7. Dou M, Chen Y, Hu J, Ma D, Xing Y. Recent advancements
Visualization: Tushar Menon, Vipan Chahil, Dhruv Patel, in CD47 signal transduction pathways involved in vascular
Corina Grancorvitz diseases. Biomed Res Int. 2020;2020:4749135.
Writing – original draft: Tushar Menon, Vipan Chahil, doi: 10.1155/2020/4749135
Dhruv Patel, Corina Grancorvitz
Writing – review & editing: Krishnaswami Vijayraghavan 8. Yarmohammadi F, Karimi G. Serum and glucocorticoid-
regulated kinase 1 (SGK1) as an emerging therapeutic target
Ethics approval and consent to participate for cardiac diseases. Pharmacol Res. 2024;208:107369.
doi: 10.1016/j.phrs.2023.107369
Not applicable.
9. Escopy S, Chaikof EL. Targeting the P-selectin/PSGL-1
Consent for publication pathway: Discovery of disease-modifying therapeutics for
disorders of thromboinflammation. Blood Vessels Thromb
Not applicable. Hemost. 2024;1(3):100015.
Availability of data doi: 10.1016/j.bvth.2024.100015

Not applicable. 10. Di Candia AM, Avila DX, Moreira GR, Villacorta H,
Maisel AS. Growth differentiation factor-15, a novel
Further disclosure systemic biomarker of oxidative stress, inflammation, and
cellular aging: Potential role in cardiovascular diseases. Am
Part II of this review can be accessed at doi: 10.36922/ Heart J Plus. 2021;9:100046.
GTM025100024
doi: 10.1016/j.ahjo.2021.100046
References 11. Wolf D, Ley K. Immunity and inflammation in

1. Mensah GA, Fuster V, Murray CJL, Global Burden of atherosclerosis. Circ Res. 2019;124(2):315-327.
Cardiovascular Diseases and Risks Collaborators. Global doi: 10.1161/CIRCRESAHA.118.313591
burden of cardiovascular diseases and risks, 1990-2022. 12. Hansson GK. Immune mechanisms in atherosclerosis.
J Am Coll Cardiol. 2023;82(25):2350-2473.
Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.
doi: 10.1016/j.jacc.2023.11.007
doi: 10.1161/hq1201.100220
2. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart
disease and stroke statistics: A report of US and global 13. Tall AR, Bornfeldt KE. Inflammasomes and atherosclerosis:
data from the American Heart Association. Circulation. A mixed picture. Circ Res. 2023;132(11):1505-1520.
2024;149(8):e347-e913. doi: 10.1161/CIRCRESAHA.123.321637

Volume 4 Issue 3 (2025) 10 doi: 10.36922/GTM025100023